¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.
Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2012³â vaccine ¿¡ ÃâÆǵÈ
"Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway" ÀÔ´Ï´Ù.
ÀÌ ³í¹®Àº ginsenoside Rg1, Re °¡ adjuvant ·Î½á ¾î¶² mechanism À¸·Î ÀÛ¿ëÇÏ´Â Áö ¿¬±¸ÇÑ ³í¹®ÀÔ´Ï´Ù. TLR4 KO ¸¶¿ì½º¿Í reporter cell assay µîÀ» ÀÌ¿ëÇÏ¿© Rg1 °ú Re ÀÇ adjuvant activity °¡ TLR4 signaling pathway ¿Í ¿¬°üµÇ¾î ÀÖ´Ù´Â °ÍÀ» ¹àÇû½À´Ï´Ù.
¿À·¡µÈ ³í¹®À̱â´Â ÇÏÁö¸¸ ginsenoside ¸¦ adjuvant ·Î½á »ç¿ëÇÏ°í ±× mechanism À» ¹àÈù ¸î ¾ÈµÇ´Â ¿¬±¸ Áß ÇϳªÀ̱⠶§¹®¿¡ °ü·Ã ³»¿ë °øºÎ¸¦ À§ÇØ ¼±Á¤ÇÏ¿´½À´Ï´Ù.
Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
±è¼öÁö µå¸²
³í¹®»çÀÌÆ®:
Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway - ScienceDirect